To Investigate the Effect of Continuous Versus Interrupted Subcutaneous Fat Closure in Reducing Surgical Site Infection Among Over-weight or Obese Women Who Are Undergoing Elective Caesarean Section
Overweight or Obese Women, Elective Lower Segment Cesarean Section
About this trial
This is an interventional prevention trial for Overweight or Obese Women, Elective Lower Segment Cesarean Section
Eligibility Criteria
Inclusion Criteria: Overweight/Obese Women > 25kg/m2, measured in the first trimester Single Fetus Gestational Age (37-41) week calculated by sure dates and confirmed by first trimester ultrasound Elective Lower Segment Cesarean Section Exclusion Criteria: Patients who are immune-compromised e.g. Known Diabetes Mellitus or HIV positive mothers Patients who are on long term Steroid use: e.g. SLE, Rheumatoid Arthritis Multifetal Pregnancy Those with anemia, requiring transfusion Obstetric Complications: e.g. Placenta Previa Any mother who wishes not to participate in the study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
continuous subcutaneous tissue closure
Interrupted subcutaneous tissue closure
continuous subcutaneous tissue closure
Interrupted subcutaneous tissue closure